Pyrimido[5,4-d][1]benzazepin-6-ones 1 are a class of potent dual inhibitors of the polo-like kinase 1 (PLK1) and the vascular endothelial growth factor receptor kinase 2 (VEGF-R2) with antiproliferative activity against cancer cell lines [4]. Here, PLK1 is linked to cancer.